Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rick Admiraal

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
The Lancet. Haematology|June 27, 2020
Anti-thymocyte globulin for GVHD: one dose does not fit allRick Admiraal, Jaap J Boelens
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Antithymocyte Globulin: Steps Toward Individualized DosingRick Admiraal, Jaap J Boelens
British Journal of Haematology|April 6, 2026
Serotherapy in transplant: Getting it right!Robert Wynn, Rick Admiraal, Caroline Lindemans
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2018
Fine-Tuning Antithymocyte Globulin Dosing and Harmonizing Clinical Trial DesignJaap Jan Boelens, Rick Admiraal, Jurgen Kuball, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 2019
Pharmacological Considerations in Antithymocyte Globulin Exposure CalculationRick Admiraal, Moniek A de Witte, Alwin Huitema, et al.
The Journal of Allergy and Clinical Immunology|May 24, 2016
Antithymocyte globulin: Importance of good clinical pharmacological practiceRick Admiraal, Charlotte van Kesteren, Stefan Nierkens, et al.
Blood Advances|March 1, 2018
Human herpesvirus 6 viremia affects T-cell reconstitution after allogeneic hematopoietic stem cell transplantationCoco de Koning, Rick Admiraal, Stefan Nierkens, et al.
Stem Cell Investigation|June 14, 2017
Immune reconstitution and outcomes after conditioning with anti-thymocyte-globulin in unrelated cord blood transplantation; the good, the bad, and the uglyCoco de Koning, Rick Admiraal, Stefan Nierkens, et al.
Frontiers in Pediatrics|January 24, 2022
Serotherapy as Graft-Versus-Host Disease Prophylaxis in Haematopoietic Stem Cell Transplantation for Acute Lymphoblastic LeukaemiaSteven J Keogh, Jean-Hugues Dalle, Rick Admiraal, et al.
Bone Marrow Transplantation|May 19, 2019
Consensus recommendations for the role and competencies of the EBMT clinical pharmacist and clinical pharmacologist involved in hematopoietic stem cell transplantationClaudia Langebrake, Rick Admiraal, Erik van Maarseveen, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
The Lancet. Haematology|June 27, 2020
Anti-thymocyte globulin for GVHD: one dose does not fit allRick Admiraal, Jaap J Boelens
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Antithymocyte Globulin: Steps Toward Individualized DosingRick Admiraal, Jaap J Boelens
British Journal of Haematology|April 6, 2026
Serotherapy in transplant: Getting it right!Robert Wynn, Rick Admiraal, Caroline Lindemans
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2018
Fine-Tuning Antithymocyte Globulin Dosing and Harmonizing Clinical Trial DesignJaap Jan Boelens, Rick Admiraal, Jurgen Kuball, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 2019
Pharmacological Considerations in Antithymocyte Globulin Exposure CalculationRick Admiraal, Moniek A de Witte, Alwin Huitema, et al.
The Journal of Allergy and Clinical Immunology|May 24, 2016
Antithymocyte globulin: Importance of good clinical pharmacological practiceRick Admiraal, Charlotte van Kesteren, Stefan Nierkens, et al.
Blood Advances|March 1, 2018
Human herpesvirus 6 viremia affects T-cell reconstitution after allogeneic hematopoietic stem cell transplantationCoco de Koning, Rick Admiraal, Stefan Nierkens, et al.
Stem Cell Investigation|June 14, 2017
Immune reconstitution and outcomes after conditioning with anti-thymocyte-globulin in unrelated cord blood transplantation; the good, the bad, and the uglyCoco de Koning, Rick Admiraal, Stefan Nierkens, et al.
Frontiers in Pediatrics|January 24, 2022
Serotherapy as Graft-Versus-Host Disease Prophylaxis in Haematopoietic Stem Cell Transplantation for Acute Lymphoblastic LeukaemiaSteven J Keogh, Jean-Hugues Dalle, Rick Admiraal, et al.
Bone Marrow Transplantation|May 19, 2019
Consensus recommendations for the role and competencies of the EBMT clinical pharmacist and clinical pharmacologist involved in hematopoietic stem cell transplantationClaudia Langebrake, Rick Admiraal, Erik van Maarseveen, et al.
Pageof 4